• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-FDG PET/MRI 多模态成像在肝细胞癌中对细胞角蛋白 19 状态的识别价值。

The added value of F-FDG PET/MRI multimodal imaging in hepatocellular carcinoma for identifying cytokeratin 19 status.

机构信息

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.

Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.

出版信息

Abdom Radiol (NY). 2023 Jul;48(7):2331-2339. doi: 10.1007/s00261-023-03911-3. Epub 2023 Apr 29.

DOI:10.1007/s00261-023-03911-3
PMID:37119293
Abstract

PURPOSE

In hepatocellular carcinoma (HCC), cytokeratin 19(CK19) has been proven to be associated with clinical aggressiveness. Therefore, this study aimed to explore the added value of F-FDG PET/MRI in predicting CK19 status in HCC.

METHODS

Sixty-six patients who underwent whole-body or abdominal F-FDG PET/MRI after conventional PET/CT for HCC were retrospectively enrolled. The maximal standard uptake value (T-SUVmax) and the mean apparent diffusion coefficient (T-ADCmean) of the tumor (T), as well as those of the normal liver tissues (L) were derived, followed by calculations of the T-SUVmax/L-SUVmax (SUVmax-T/L) and the T-ADCmean/L-ADCmean (ADCmean-T/L) ratios. Combined with the postoperative pathological results, the performance in predicting the CK19 status in HCC was evaluated using receiver operating characteristic analysis (ROC).

RESULTS

The areas under the ROC curve (AUCs) for T-SUVmax, SUVmax-T/L, T-ADCmean, and ADCmean-T/L in predicting the CK19-positive HCC were 0.700, 0.717, 0.717, and 0.735, respectively. In the logistic regression analysis, the T-SUVmax was an independent and significant factor to predict CK19-positive HCC, with an odds ratio of 1.27. In addition, no significant differences were found in the pathological grading, microvascular invasion, liver capsular invasion, Hepatitis B virus (HBV) infection, alpha fetoprotein (AFP) level, and tumor diameter between the CK19-positive and CK19-negative groups, except the recurrent rate.

CONCLUSIONS

The radiomic features derived from F-FDG PET/MRI can be used to predict the CK19 status of HCC. T-SUVmax and T-ADCmean were significant indicators, whereas T-SUVmax was an independent predictor.

摘要

目的

在肝细胞癌(HCC)中,细胞角蛋白 19(CK19)已被证明与临床侵袭性相关。因此,本研究旨在探讨 F-FDG PET/MRI 在预测 HCC 中 CK19 状态方面的附加价值。

方法

回顾性纳入 66 例在 HCC 常规 PET/CT 后行全身或腹部 F-FDG PET/MRI 的患者。得出肿瘤(T)的最大标准摄取值(T-SUVmax)和平均表观扩散系数(T-ADCmean)以及正常肝组织(L)的 T-SUVmax 和 T-ADCmean,随后计算 T-SUVmax/L-SUVmax(SUVmax-T/L)和 T-ADCmean/L-ADCmean(ADCmean-T/L)比值。结合术后病理结果,采用受试者工作特征曲线(ROC)分析评估 F-FDG PET/MRI 对 HCC 中 CK19 状态的预测性能。

结果

T-SUVmax、SUVmax-T/L、T-ADCmean 和 ADCmean-T/L 预测 CK19 阳性 HCC 的 ROC 曲线下面积(AUCs)分别为 0.700、0.717、0.717 和 0.735。在 logistic 回归分析中,T-SUVmax 是预测 CK19 阳性 HCC 的独立且重要因素,优势比为 1.27。此外,除了复发率外,CK19 阳性组和 CK19 阴性组在病理分级、微血管侵犯、肝包膜侵犯、乙型肝炎病毒(HBV)感染、甲胎蛋白(AFP)水平和肿瘤直径方面无显著差异。

结论

F-FDG PET/MRI 衍生的放射组学特征可用于预测 HCC 的 CK19 状态。T-SUVmax 和 T-ADCmean 是显著指标,而 T-SUVmax 是独立预测因子。

相似文献

1
The added value of F-FDG PET/MRI multimodal imaging in hepatocellular carcinoma for identifying cytokeratin 19 status.F-FDG PET/MRI 多模态成像在肝细胞癌中对细胞角蛋白 19 状态的识别价值。
Abdom Radiol (NY). 2023 Jul;48(7):2331-2339. doi: 10.1007/s00261-023-03911-3. Epub 2023 Apr 29.
2
Investigating the value of pre-treatment F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation.探讨治疗前F-FDG PET/CT在预测肝细胞癌病理特征及肝移植术后复发方面的价值。
Abdom Radiol (NY). 2021 Jun;46(6):2490-2497. doi: 10.1007/s00261-020-02872-1. Epub 2021 Jan 2.
3
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.18F-FDG PET/CT 对肝癌患者肝移植前血管侵犯的预测价值。
Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.
4
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.18F-FDG PET对肝细胞癌肝移植术后肿瘤复发的预测
J Nucl Med. 2009 May;50(5):682-7. doi: 10.2967/jnumed.108.060574. Epub 2009 Apr 16.
5
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.肝胆磁共振对比剂摄取作为预测病理侵袭性特征和降低可切除肝细胞癌无复发生存率的生物标志物:与双示踪剂 18F-FDG 和 18F-FCH PET/CT 的比较。
Eur Radiol. 2020 Oct;30(10):5348-5357. doi: 10.1007/s00330-020-06923-5. Epub 2020 May 13.
6
The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma.术前 18F-FDG PET 代谢和容积参数在预测肝细胞癌微血管侵犯和术后复发中的价值。
Nucl Med Commun. 2022 Jan 1;43(1):100-107. doi: 10.1097/MNM.0000000000001478.
7
Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.多参数 FDG-PET/MRI 对肝细胞癌的诊断:初步经验。
Contrast Media Mol Imaging. 2018 Oct 3;2018:5638283. doi: 10.1155/2018/5638283. eCollection 2018.
8
Exploring the efficacy of F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation.探讨 F-FDG PET/CT 在肝细胞癌诊断中的疗效:Ki-67 指数与肿瘤分化的作用。
Abdom Radiol (NY). 2023 Nov;48(11):3408-3419. doi: 10.1007/s00261-023-04027-4. Epub 2023 Sep 8.
9
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.联合预处理MRI和18F-FDG PET/CT参数作为宫颈癌患者的预后生物标志物
Eur J Radiol. 2014 Jul;83(7):1169-1176. doi: 10.1016/j.ejrad.2014.03.024. Epub 2014 Mar 30.
10
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.对比增强 FDG PET/CT 在桥接治疗肝细胞癌后甲胎蛋白升高的肝移植患者中的疗效。
Eur Radiol. 2018 Dec;28(12):5356-5367. doi: 10.1007/s00330-018-5425-z. Epub 2018 Jun 12.

引用本文的文献

1
Radiomics and Deep Learning as Important Techniques of Artificial Intelligence - Diagnosing Perspectives in Cytokeratin 19 Positive Hepatocellular Carcinoma.放射组学和深度学习作为人工智能的重要技术——细胞角蛋白19阳性肝细胞癌的诊断前景
J Hepatocell Carcinoma. 2025 Jun 5;12:1129-1140. doi: 10.2147/JHC.S526887. eCollection 2025.
2
[A deep learning model based on magnetic resonance imaging and clinical feature fusion for predicting preoperative cytokeratin 19 status in hepatocellular carcinoma].基于磁共振成像与临床特征融合的深度学习模型预测肝细胞癌术前细胞角蛋白19状态
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Sep 20;44(9):1738-1751. doi: 10.12122/j.issn.1673-4254.2024.09.14.
3

本文引用的文献

1
A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.基于影像组学的钆塞酸增强 MRI 肝细胞癌细胞角蛋白 19 状态的生物标志物
Eur Radiol. 2020 May;30(5):3004-3014. doi: 10.1007/s00330-019-06585-y. Epub 2020 Jan 30.
2
Validation of MR-Based Attenuation Correction of a Newly Released Whole-Body Simultaneous PET/MR System.基于 MR 的新型全身同时 PET/MR 系统衰减校正的验证。
Biomed Res Int. 2019 Nov 28;2019:8213215. doi: 10.1155/2019/8213215. eCollection 2019.
3
Impact of patient comfort on diagnostic image quality during PET/MR exam: A quantitative survey study for clinical workflow management.
Diagnostic value of radiomics in predicting Ki-67 and cytokeratin 19 expression in hepatocellular carcinoma: a systematic review and meta-analysis.
放射组学在预测肝细胞癌中Ki-67和细胞角蛋白19表达的诊断价值:一项系统评价和荟萃分析
Front Oncol. 2024 Jan 3;13:1323534. doi: 10.3389/fonc.2023.1323534. eCollection 2023.
探讨患者舒适度对 PET/MR 检查诊断图像质量的影响:一项针对临床工作流程管理的定量调查研究。
J Appl Clin Med Phys. 2019 Jul;20(7):184-192. doi: 10.1002/acm2.12664. Epub 2019 Jun 17.
4
Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management.扩散加权成像在肝脏肿瘤中的应用价值及其对患者管理的影响。
Cancer Imaging. 2018 Mar 7;18(1):10. doi: 10.1186/s40644-018-0140-1.
5
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
6
Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.钆塞酸增强及弥散加权磁共振成像在识别细胞角蛋白 19 阳性肝细胞癌中的影像学特征:一项回顾性观察研究。
Radiology. 2018 Mar;286(3):897-908. doi: 10.1148/radiol.2017162846. Epub 2017 Nov 21.
7
Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.HMG CoA还原酶抑制剂对慢性肺移植功能障碍发展的影响。
Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13156. Epub 2017 Dec 8.
8
Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.角蛋白 19,人肝癌中的癌症干细胞标志物。
Clin Cancer Res. 2015 Jul 1;21(13):3081-91. doi: 10.1158/1078-0432.CCR-14-1936. Epub 2015 Mar 27.
9
Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.表达“干性”相关标志物的肝细胞癌:临床病理特征
Dig Dis. 2014;32(6):778-85. doi: 10.1159/000368021. Epub 2014 Oct 29.
10
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.在肝癌切除术后,细胞角蛋白 19 在淋巴结中的表达是一个预后不良的因素。
World J Surg Oncol. 2013 Jun 12;11(1):136. doi: 10.1186/1477-7819-11-136.